AU2273397A - Methods and compositions for modulating an immune response - Google Patents

Methods and compositions for modulating an immune response

Info

Publication number
AU2273397A
AU2273397A AU22733/97A AU2273397A AU2273397A AU 2273397 A AU2273397 A AU 2273397A AU 22733/97 A AU22733/97 A AU 22733/97A AU 2273397 A AU2273397 A AU 2273397A AU 2273397 A AU2273397 A AU 2273397A
Authority
AU
Australia
Prior art keywords
modulating
compositions
methods
immune response
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22733/97A
Inventor
Richard J Armitage
Carlos Escobar
William C Fanslow
Jodee Zappone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of AU2273397A publication Critical patent/AU2273397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU22733/97A 1996-02-15 1997-02-13 Methods and compositions for modulating an immune response Abandoned AU2273397A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60195496A 1996-02-15 1996-02-15
US601954 1996-02-15
US67375396A 1996-06-27 1996-06-27
US673753 1996-06-27
US72028496A 1996-09-26 1996-09-26
US720284 1996-09-26
PCT/US1997/002350 WO1997029781A1 (en) 1996-02-15 1997-02-13 Methods and compositions for modulating an immune response

Publications (1)

Publication Number Publication Date
AU2273397A true AU2273397A (en) 1997-09-02

Family

ID=27416839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22733/97A Abandoned AU2273397A (en) 1996-02-15 1997-02-13 Methods and compositions for modulating an immune response

Country Status (2)

Country Link
AU (1) AU2273397A (en)
WO (1) WO1997029781A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1631700A (en) * 1998-11-23 2000-06-13 Idec Pharmaceuticals Corporation Tumor antigen-specific antibody-gp39 chimeric protein constructs
GB2370273A (en) * 2000-12-20 2002-06-26 Viaxxel Biotech Gmbh Compounds that affect CD83 expression
US20040185040A1 (en) 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
EP1480598A4 (en) * 2001-11-21 2006-03-22 Celltech R & D Inc Manipulation of cytokine levels using cd83 gene products
EP1389480A1 (en) * 2002-08-14 2004-02-18 Mondobiotech Interferon SA Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
EP1422241A1 (en) 2002-11-19 2004-05-26 Alexander Steinkasserer Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
WO2004048552A2 (en) * 2002-11-21 2004-06-10 Celltech R & D, Inc. Modulating immune responses
US9102726B2 (en) 2002-12-04 2015-08-11 Argos Therapeutics, Inc. Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
US7169898B2 (en) 2002-12-04 2007-01-30 Alexander Steinkasserer Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
CN101484461B (en) 2006-08-18 2014-09-17 阿哥斯医疗公司 Use of cd83 in combination therapies
CN109320610B (en) * 2015-01-27 2021-07-27 中国科学技术大学先进技术研究院 Anti-human CD83 monoclonal antibody and preparation, identification and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710262A (en) * 1992-04-17 1998-01-20 Dana-Faber Cancer Institute, Inc. Nucleic acid encoding HB15 polypeptides
US5316920A (en) * 1992-04-17 1994-05-31 Dana-Faber Cancer Institute, Inc. Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily

Also Published As

Publication number Publication date
WO1997029781A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU3767097A (en) Shampoo compositions and method
AU3249793A (en) Compositions and methods for modulating beta -amyloid
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU2825597A (en) Elastomer compositions and methods
AU2013797A (en) Creating and using an adaptable multiple-contract transaction object
AU4520797A (en) Hydroxyphenyltriazines
AU4997397A (en) Card-recognition and gaming-control device
AU4985497A (en) Fat-coated encapsulation compositions and method for preparing the same
AU4261697A (en) Compounds and methods
AU2514592A (en) Methods and compositions for modulating g protein action
AU3063597A (en) Polyalkylphenoxyaminoalkanes and fuel compositions containing the same
EP0690494A3 (en) Connection and build-up-process for multi-chip-modules
AU2972597A (en) Compositions and uses thereof
IL145891A0 (en) Methods and compositions for modulating an immune response
AU7968398A (en) Compositions, devices, kit and method for modulating immune response
AU2748497A (en) Modified rosin emulsion
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU5157898A (en) Hnf3delta compositions
AU7685798A (en) Compositions and methods for preventing adhesion
AU2273397A (en) Methods and compositions for modulating an immune response
AU4876397A (en) Insecticidal compositions and methods
AU3200197A (en) New composition and methods
AUPN137895A0 (en) Composition and method